Testosterone Therapy and PCa Risk in Hypogonadal Men Testosterone Therapy and PCa Risk in Hypogonadal Men
Dr Chodak reviews a ' provocative ' study on the risk for prostate cancer in men receiving testosterone therapy for hypogonadism.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 27, 2017 Category: Consumer Health News Tags: Urology Commentary Source Type: news
FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use
[03-03-2015] The U.S. Food and Drug Administration (FDA) cautions that prescription testosterone products are approved only for men who have low testosterone levels caused by certain medical conditions. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 11, 2017 Category: Drugs & Pharmacology Source Type: news
Low testosterone levels linked to lower prostate cancer risk
According to a study, presented at the National Cancer Research Institute Cancer Conference, men with lower testosterone levels are less likely to develop prostate cancer. Independent (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 10, 2017 Category: Endocrinology Source Type: news
Medical News Today: Men with low testosterone less likely to have prostate cancer
New study findings confirm the so-called androgen receptor saturation theory and may help to reduce prostate cancer risk in the future. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 6, 2017 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
How low testosterone levels can cut prostate cancer risk
The discovery could lead to new methods of treatment by reducing the hormone. (Source: the Mail online | Health)
Source: the Mail online | Health - November 4, 2017 Category: Consumer Health News Source Type: news
Low testosterone in women: Mayo Clinic Radio Health Minute
Low testosterone or low-T is typically thought of as a male issue. ?But in this Mayo Clinic Radio Health Minute, Dr. Stephanie Faubion says women can also experience symptoms related to low testosterone levels. To listen, click the link below. Low Testosterone in Women (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 3, 2017 Category: Databases & Libraries Source Type: news
Aytu BioScience Provides Quarterly Update on the Natesto(R) U.S. Launch
ENGLEWOOD, Colo., Oct. 26, 2017 -- (Healthcare Sales & Marketing Network) -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an update on... Biopharmaceuticals, Drug Delivery, Product Launch Aytu BioScience, Natesto, testosterone, low testosterone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 26, 2017 Category: Pharmaceuticals Source Type: news
Prostate problem? Take 2 nuts
By age 60, you have a 50/50 chance of having a clinically enlarged prostate. And it only gets worse every year. When your prostate isn’t functioning properly, it’s hard to enjoy life.
Traditional doctors give you two choices.
Go under the knife or you take Big Pharma’s drugs.
Either way, you have a good chance of ending up with your manhood on the line…
If you have surgery, there’s a big risk you’ll be saying goodbye to your sex life for good. The rate of impotence is a shocking 50 to 60% after prostate surgery.1
Big Pharma’s meds to shrink your prostate are no better. These synthetic drugs have a history ...
Source: Al Sears, MD Natural Remedies - October 19, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news
Calcium Essential to Limit Osteoporosis but Avoid Excess, Say Europeans Calcium Essential to Limit Osteoporosis but Avoid Excess, Say Europeans
Calcium levels of 700-1200 mg/day are recommended in postmenopausal women, but excessive doses could be harmful, highlights a new clinical guide from the European Menopause and Andropause Society.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 19, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Colorado 'sexual wellness' firm moving to bigger exchange after stock split
An Arapahoe County company that specializes in treating low testosterone in men and diagnosing male infertility is moving its shares to the Nasdaq stock exchange.
Aytu BioScience Inc., which engineered a 1-for-20 reverse split in August in an effort to make the move from the over-the-counter bulletin board exchange, said its shares ("AYTU") will begin trading on the Nasdaq exchange on Friday.
"To augment our operational progress, we believe that listing on Nasdaq will help the company further diversify… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 18, 2017 Category: American Health Authors: Ben Miller Source Type: news
CME: Can You Trust What You Read? CME: Can You Trust What You Read?
A review of accredited educational programs on hypogonadism turned up some common themes, including those not supported by the evidence.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 12, 2017 Category: Consumer Health News Tags: Internal Medicine Expert Interview Source Type: news
Calcium in the prevention of postmenopausal osteoporosis: EMAS Clinical Guide
(Elsevier) Osteoporosis is common and affects 1 in 3 women. Calcium is vital for strong healthy bones and worldwide scientific societies have issued guidance about the daily requirements from childhood to old age. The European Menopause and Andropause Society (EMAS) has issued a new clinical guide with the aim of raising awareness of the importance of calcium in lowering the risk of osteoporosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 12, 2017 Category: International Medicine & Public Health Source Type: news
Low Testosterone (Low T) Quiz: Test Your IQ of Men's Conditions
Title: Low Testosterone (Low T) Quiz: Test Your IQ of Men's ConditionsCategory: MedicineNet QuizCreated: 9/19/2012 12:29:00 PMLast Editorial Review: 9/20/2017 12:43:07 PM (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - September 20, 2017 Category: Primary Care Source Type: news
Lipocine Resubmits NDA for Its Oral Testosterone Product Candidate, LPCN 1021, for Treatment of Hypogonadism
SALT LAKE CITY, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced the resubmission of a New Drug Application ( " NDA " ) for LPCN 1021, its oral testosterone product candidate for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 9, 2017 Category: Drugs & Pharmacology Source Type: news
Testosterone Replacement Gel Therapy for Male Hypogonadism Testosterone Replacement Gel Therapy for Male Hypogonadism
This novel testosterone gel formulation may be an effective new treatment option for hypogonadal men.Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
